Showing results (1-10 of 406) with videos related to
Sort By:
Pageof 41
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Characterizing structural uncertainty in decision analytic models: a review and application of methodsLaura Bojke, Karl Claxton, Mark Sculpher, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2010
Eliciting distributions to populate decision analytic modelsLaura Bojke, Karl Claxton, Yolanda Bravo-Vergel, et al.Pharmacoeconomics|April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessmentZoë Philips, Laura Bojke, Mark Sculpher, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 12, 2008
Identifying research priorities: the value of information associated with repeat screening for age-related macular degenerationLaura Bojke, Karl Claxton, Mark J Sculpher, et al.Health Economics|December 10, 2014
Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?Karl Claxton, Mark Sculpher, Stephen Palmer, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 11, 2005
Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty--when is there sufficient evidence?Mark Sculpher, Karl ClaxtonHealth Economics|February 1, 2017
Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research NeedsClaire Rothery, Karl Claxton, Stephen Palmer, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments RequiredClaire McKenna, Marta Soares, Karl Claxton, et al.Pharmacoeconomics|January 19, 2013
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidanceLouise Longworth, Jihee Youn, Laura Bojke, et al.Pharmacoeconomics|September 25, 2007
A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORDLaura Bojke, Edward Hornby, Mark Sculpher, et al.Pageof 41